Login
$LYEL
$10.12 +$0.81 (8.7%) Close

$LYEL 4 SEC Filings

Filed On Filing
13 Oct 2026 Form 4: Aguirre Jarrad Mattieu, Chief Medical Officer

Sold 422 shares ($3.64K)

10 Sep 2026 Form 4: Aguirre Jarrad Mattieu, Chief Medical Officer

Granted 47,500 Option (right to buy)

10 Sep 2026 Form 4: Shook David, Chief Medical Officer

Sold 500 shares ($6.35K)

25 Aug 2026 Form 4: Seely Lynn, Director

Sold 9,589 shares ($149K)

25 Aug 2026 Form 4: Hill Stephen J., Chief Operating Officer

Sold 989 shares ($15.4K)

25 Aug 2026 Form 4: Lee Gary K., Chief Scientific Officer

Sold 1,457 shares ($22.6K)

11 Aug 2026 Form 4: Bulis Veronica Sanchez, VP, Corporate Controller

Sold 621 shares ($8.91K)

11 Aug 2026 Form 4: Lee Gary K., Chief Scientific Officer

Sold 131 shares ($1.88K)

11 Aug 2026 Form 4: Hill Stephen J., Chief Operating Officer

Sold 89 shares ($1.28K)

11 Aug 2026 Form 4: Seely Lynn, Director

Sold 390 shares ($5.59K)

27 Jul 2026 Form 4: Innovative Cellular Therapeutics Holdings Ltd, 10% owner

Disposed of 44,000 shares (Other Transaction)

27 Jul 2026 Form 4: Innovative Cellular Therapeutics Holdings Ltd, 10% owner

Disposed of 38,500 shares (Other Transaction)

20 Jul 2026 Form 4: Innovative Cellular Therapeutics Holdings Ltd, 10% owner

Sold 10 shares ($137)

17 Jul 2026 Form 4: Innovative Cellular Therapeutics Holdings Ltd, 10% owner

Sold 10 shares ($137)

01 Jul 2026 Form 4: Innovative Cellular Therapeutics Holdings Ltd, 10% owner

Disposed of 76,000 shares (Other Transaction)

18 Jun 2026 Form 4: Innovative Cellular Therapeutics Holdings Ltd, 10% owner

Disposed of 66,500 shares (Other Transaction)

15 Jun 2026 Form 4: Lee Gary K., Chief Scientific Officer

Sold 130 shares ($2.46K)

15 Jun 2026 Form 4: Hill Stephen J., Chief Operating Officer

Sold 89 shares ($1.68K)

15 Jun 2026 Form 4: Bulis Veronica Sanchez, VP, Corporate Controller

Sold 217 shares ($4.1K)

15 Jun 2026 Form 4: Seely Lynn, Director

Sold 388 shares ($7.34K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support